Maybank Lifts TSH to Buy After 3Q Results, Sees Indonesian Regulatory Risk Largely Priced In
Ng Han Siang (Einod) ·
AI-assisted, reviewed by Ng Han Siang (Einod)
Maybank Investment Bank analyst Ong Chee Ting upgraded TSH Resources to “Buy” from “Hold”, even as he lowered his target price to RM1.31 from RM1.33. He believes the recent share-price correction has largely priced in Indonesia’s regulatory risk. His revised target implies about 20% potential total return, including dividends.
TSH’s reported 3Q26 net profit fell 69% year-on-year to RM17.8 million after a RM42 million administrative fine in Indonesia. Excluding the fine, core net profit rose 12% to RM60 million, beating expectations as higher fresh fruit bunch production and lower operating costs offset weaker palm product prices.
Ong expects reported net profit to recover in 4Q26 as the one-off fine drops out. He expects core earnings to ease quarter-on-quarter as palm oil prices soften and below-normal rainfall in Indonesia threatens fresh fruit bunch output. He also sees the buyback programme as a cushion for the share price, with TSH repurchasing about 49 million shares over the eight months to mid-November.
As of 10:00 a.m. on November 19, TSH Resources’ share price fell 1.8% to RM1.10.
Disclaimer: All content is AI-aggregated from public sources for informational and educational purposes only. StockTipRatings.com does not constitute investment advice. Past performance and historical statistics are no guarantee of future returns.
The call: Maybank on TSH RESOURCES BERHAD
- Rating
- Buy
- Target price
- RM 1.31 (from RM 1.33)
Ong Chee Ting's 12-month track record
No.4 of 19 analysts at Maybank
- Success rate
- 71%
- Average return
- 12%
- Stocks covered
- 8
Consensus target price for TSH
Sign up free to see the consensus target, or read the TSH target price and analyst ratings.